Literature DB >> 16020313

HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: review and perspective.

Dennis W Schultz1, Richard G Weleber, Gus Lawrence, Sandra Barral, Jacek Majewski, Ted S Acott, Michael L Klein.   

Abstract

Age-related macular degeneration (AMD) is the most common blinding disorder in the Western world. Similar to other common diseases in which age is a risk factor (e.g., type II diabetes or Alzheimer's disease), AMD is thought to have a complex etiology. Previously, a Gln5345Arg mutation in HEMICENTIN-1 was found to segregate with AMD in a large family. However, the population frequency of this allele is inconsistent with the large proportion of families shown by linkage studies to map near this gene at 1q31. This review summarizes current knowledge regarding the role of HEMICENTIN-1 in AMD, the results of association studies for the Gln5345Arg mutation, and the linkage evidence for an AMD locus on 1q31. The data can be reconciled through proposing both additional variants in HEMICENTIN-1 and a second genetic risk factor for AMD in the region.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020313     DOI: 10.1080/13816810590968023

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  17 in total

1.  Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD) : Drusen subdomains in fibulin-5 AMD.

Authors:  Murat Kucukevcilioglu; Chetankumar B Patel; Edwin M Stone; Stephen R Russell
Journal:  Int Ophthalmol       Date:  2015-12-23       Impact factor: 2.031

Review 2.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

3.  Unfolding the Therapeutic Potential of Chemical Chaperones for Age-related Macular Degeneration.

Authors:  Theodor Sauer; Mrinali Patel; Chi-Chao Chan; Jingsheng Tuo
Journal:  Expert Rev Ophthalmol       Date:  2008-02

4.  Examination of association with candidate genes for diabetic nephropathy in a Mexican American population.

Authors:  Sulgi Kim; Hanna E Abboud; Madeleine V Pahl; John Tayek; Susan Snyder; James Tamkin; Harry Alcorn; Eli Ipp; Cynthia C Nast; Robert C Elston; Sudha K Iyengar; Sharon G Adler
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

Review 5.  Highly penetrant alleles in age-related macular degeneration.

Authors:  Anneke I den Hollander; Eiko K de Jong
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

6.  Repository of proposed pathways and protein-protein interaction networks in age-related macular degeneration.

Authors:  Fran M Pool; Christina Kiel; Luis Serrano; Philip J Luthert
Journal:  NPJ Aging Mech Dis       Date:  2020-01-07

7.  Polymorphism p.402Y>H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian population.

Authors:  F Simonelli; G Frisso; F Testa; R di Fiore; D F Vitale; M P Manitto; R Brancato; E Rinaldi; L Sacchetti
Journal:  Br J Ophthalmol       Date:  2006-06-14       Impact factor: 4.638

8.  Impaired cholesterol efflux in retinal pigment epithelium of individuals with juvenile macular degeneration.

Authors:  Yi-Ting Tsai; Yao Li; Joseph Ryu; Pei-Yin Su; Chia-Hua Cheng; Wen-Hsuan Wu; Yong-Shi Li; Peter M J Quinn; Kam W Leong; Stephen H Tsang
Journal:  Am J Hum Genet       Date:  2021-04-27       Impact factor: 11.025

9.  The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

Authors:  Peter James Francis
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

10.  Differential expression of fibulin family proteins in the para-cervical weak zone and other areas of human fetal membranes.

Authors:  R M Moore; R W Redline; D Kumar; B M Mercer; J M Mansour; E Yohannes; J B Novak; M R Chance; J J Moore
Journal:  Placenta       Date:  2009-02-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.